PRevEntion of cardiac and Vascular pEriprocedural complications in patients undergoiNg coronary angiography or angioplasTy: IntraCoronary Adenosine administration to prevent peRiprocedUral myonecrosiS in elective coronary angioplasty. A prospective double-blind randomized trial (PREVENT ICARUS) trial.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Adenosine (Primary)
- Indications Heart failure
- Focus Pharmacodynamics; Therapeutic Use
- Acronyms PREVENT-ICARUS
Most Recent Events
- 15 Mar 2012 Planned end date 29 Apr 2010 added as reported by EudraCT.
- 08 Nov 2011 Biomarkers information updated
- 28 Jun 2011 New trial record